GleanMark

MYNAVCARE BY GENMAB Trademark

MYNAVCARE BY GENMAB is a USPTO trademark filed by Genmab A/S. Status: Registered.

Prosecution Summary

Trademark Summary
The mark is MYNAVCARE BY GENMAB, a standard character word mark, used as a service mark for consumer information and business administrative services for patient reimbursement and medical benefit support, and for financial administration and charitable services related to patient reimbursement and assistance programs, as well as medical assistance and disease management programs, including medical counseling and healthcare information in connection with disease management and treatment reimbursement—all specifically in the field of treatment with monoclonal antibody anticancer medications, and with a stated limitation excluding Massachusetts seniors who are Medicaid/MassHealth beneficiaries or dual-eligible Medicare and Medicaid/MassHealth beneficiar

Trademark Facts

MarkMYNAVCARE BY GENMAB
Serial Number97936794
Registration Number7819914
StatusRegistered
Filing Date2023-05-15
Registration Date2025-06-03
Mark TypeWord
Nice Classes035 (Advertising & Business), 036 (Financial Services), 041 (Education & Entertainment), 044 (Medical Services), 045 (Legal Services)
OwnerGenmab A/S
Attorney of RecordMax Vern
Prosecution Events45
Latest EventR.PR on 2025-06-03

Goods & Services

Financial administration of patient reimbursement and patient financial assistance programs, namely reimbursement payment processing in the field of pharmaceutical and medical claims; Charitable services, namely, providing financial support to disadvantaged patients for the purpose of reimbursing medical and pharmaceutical expenses; Providing counseling and consulting in the field of healthcare insurance benefits in connection with patient reimbursement and patient financial assistance programs; Providing information about healthcare insurance plans, patient financial assistance, and patient reimbursement programs; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries; Provision of consumer information in the field of patient reimbursement and medical benefit support; Business administrative services for medical referrals in connection to patient reimbursement programs; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries; Medical assistance, namely disease management programs; provision of health care information in connection to disease management and navigation through medical treatments; provision of medical information in connection with health conditions and treatment of these conditions; medical counseling for patients in connection with disease management; Consultancy in the field of the medical treatment of cancer, autoimmune diseases, and inflammatory disorders; providing information to patients and families of patients in the field of administering medication and choosing treatments; providing a website featuring information in the medical and health fields in connection to disease management and navigation through medical treatments; health care services, namely disease management programs; medical and pharmaceutical consultation in connection to disease management; medical services, namely, provision of medical information for supporting patients in relation to the reimbursement of medical expenses; Providing a web site featuring medical information for patients in relation to the reimbursement of medical expenses; all in the field of treatment with monoclonal antibody anticancer medications; none of the above aimed at Massachusetts seniors who are Medicaid/MassHealth beneficiaries or are dual-eligible Medicare and Medicaid/MassHealth beneficiaries

Related